Peptide record

TPDB87414

RGD-GNNNQNY-CPT Selfassembly modified_plain modified
10 source-reported length (unverified)
Basic Information
TPDB87414
RGD-GNNNQNY-CPT
Selfassembly
Self-assembling and biomaterial peptides
ScienceDirect
modified_plain
Yes
A modified selfassembly peptide record curated from ScienceDirect, without an available 3D structural model. Source-reported length: 10 (unverified).
Modified, details unspecified
Sequence
RGD-GNNNQNY-CPT

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
10 source-reported length (unverified)
Self-Assembly Information 1 records
Record 1 ScienceDirect

Source

10.1016/j.biomaterials.2021.121139
Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency

Self-Assembly

Nanostructure formation
Self-assembled peptide-drug conjugate nanostructure
Tumor/cell-targeted in situ assembly
Selfassembly; Nanostructure=Self-assembled peptide-drug conjugate nanostructure; Trigger=Tumor/cell-targeted in situ assembly
Self-assembly characterization cell-entry and animal therapeutic-window assays
Cancer therapy
drug carrier active peptide
ScienceDirect
Selfassembly
Evidence Records 1 records
Evidence 1 Selfassembly

Activity

Nanostructure formation
Selfassembly Nanostructure=Self-assembled peptide-drug conjugate nanostructure Trigger=Tumor/cell-targeted in situ assembly
Self-assembled peptide-drug conjugate nanostructure

Source & Reference

NA
ScienceDirect
10.1016/j.biomaterials.2021.121139

Other

Camptothecin payload conjugated RGD targeting motif
Cancer therapy
drug carrier active peptide
Tumor/cell-targeted in situ assembly
Self-assembly characterization cell-entry and animal therapeutic-window assays
Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency
Assembly motif is GNNNQNY payload is CPT.
Additional Detail Fields 6 fields
Tumor/cell-targeted in situ assembly
Camptothecin payload conjugated RGD targeting motif
Assembly motif is GNNNQNY payload is CPT.
Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency
Cancer therapy
drug carrier active peptide